{
    "code": 0,
    "data": [
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please see enclosed Transcript of Conference Call on the Unaudited Financial Results (Standalone & Consolidated) for the quarter ended December 31 2025",
            "news_id": "b29ca260-fad2-4229-ba2c-17965f19a8a6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1052a148-c60c-4716-ae9c-4a49d73d516a.pdf",
            "news_date": "2026-01-30 17:57:51",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Conference Call on the Unaudited Financial Results (Standalone and Consolidated) for the quarter ended 31st December 2025",
            "news_id": "3308aed4-3b30-42d5-a19c-c7cf0e92af43",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=14e571e6-b421-4ea7-b782-bc5d3aaa33b7.pdf",
            "news_date": "2026-01-29 16:52:45",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclosed Investor Presentation",
            "news_id": "4618ad3c-582a-4c65-9488-324767d1593b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=94be2676-fca1-4eeb-9e5c-fa84c33674c3.pdf",
            "news_date": "2026-01-29 00:13:11",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results - Financial Results For The Quarter Ended December 31 2025",
            "news_body": "Please find enclosed Unaudited Financial Results (Standalone & Consolidated) for quarter ended December 31 2025",
            "news_id": "d8fc4190-12dd-418b-a165-f7268a90c074",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2871069a-9572-48d6-8443-199dd3b96fe8.pdf",
            "news_date": "2026-01-29 00:00:51",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please see enclosed Transcript of Conference Call on the Unaudited Financial Results (Standalone & Consolidated) for the quarter ended September 30 2025",
            "news_id": "c7e79751-3424-45c1-b2eb-6a05e3016c56",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=613b1fb0-5d63-4527-8fb7-e67860d13044.pdf",
            "news_date": "2025-11-07 15:13:23",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Conference Call on the Unaudited Financial Results (Standalone and Consolidated) for the quarter ended 30th September 2025",
            "news_id": "6018e24e-a149-42f7-95ff-26a8560e7b6f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0c3932c1-b587-4e35-9cd2-58ea4e3b0f0e.pdf",
            "news_date": "2025-11-06 12:26:21",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please see enclosed Investor Presentation - Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter and half year ended September 30 2025",
            "news_id": "89b86a6e-9c00-47d9-af4c-f2f3eeb2471e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f67db704-3ad8-48fe-baeb-efaaa2dc2d88.pdf",
            "news_date": "2025-11-05 21:05:01",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results - Financial Results For Quarter Ended September 30 2025",
            "news_body": "Please find enclosed Unaudited Financial Results (Standalone & Consolidated) for quarter ended September 30 2025",
            "news_id": "ca91db47-f232-440c-a9b7-44d69a50713d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=32a65634-dd99-4062-b6d8-2c2f6dd69041.pdf",
            "news_date": "2025-11-05 21:00:03",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Conference Call on the Unaudited Financial Results (Standalone and Consolidated) for the quarter ended 30th June 2025",
            "news_id": "d4592a45-f7e6-43eb-8f69-aab33a840ef6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=85945f2b-9feb-4628-bfd6-5969edbc57d9.pdf",
            "news_date": "2025-07-29 12:28:58",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results (Standalone & Consolidated) For The Quarter Ended 30Th June 2025",
            "news_body": "Please refer attachment",
            "news_id": "4944adbf-9431-4937-a9d1-11eb928e9f4b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f13fadb0-a355-4091-803d-ca4c581b32f6.pdf",
            "news_date": "2025-07-28 21:59:39",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation - Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter ended 30th June 2025",
            "news_id": "03e45441-4e57-4147-abe9-1ba223c26b31",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=03caf78a-1ca0-4ca9-9e2c-4f8eec46ead1.pdf",
            "news_date": "2025-07-28 21:49:37",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Conference Call on the Audited Financial Results (Standalone and Consolidated) for the financial year ended 31st March 2025",
            "news_id": "b8da426a-0a09-4552-adb6-b2cbbd5638b0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b428052b-efdb-4cb2-88e1-30e908216418.pdf",
            "news_date": "2025-05-15 14:57:33",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please refer attachment",
            "news_id": "5eee7f4c-3edc-4100-a998-a9a19f5e4394",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ba18641e-a77f-4d2d-ad62-b50bc644d450.pdf",
            "news_date": "2025-05-14 20:54:18",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results (Standalone & Consolidated) For The Quarter And Financial Year Ended 31St March 2025",
            "news_body": "Please refer attachment",
            "news_id": "5b8ebd91-4980-4467-a0b2-96815f0cbc92",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cd0d01f2-e1cb-472b-9d81-b420114031a0.pdf",
            "news_date": "2025-05-14 20:52:22",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Conference call on the Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine months ended December 31 2024",
            "news_id": "6124c83a-e147-4c69-9272-b89a0182a1f5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c0198dac-d4ee-42f4-bef0-7ce2fa830d79.pdf",
            "news_date": "2025-01-30 20:25:58",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for UFR - 31st December 2024",
            "news_id": "b0d40c06-6a5f-4ddb-989c-dea559fc5cee",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ee092d7d-2fb3-45e0-8cfd-1cc325533a34.pdf",
            "news_date": "2025-01-28 20:56:38",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results (Standalone & Consolidated) For The Quarter And Nine Months Ended 31St December 2024",
            "news_body": "Please refer attachment.",
            "news_id": "6141e5be-d310-46d9-95ae-f9f1a647c2f5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=76dfe36d-67ad-467c-a249-f49765c60fd7.pdf",
            "news_date": "2025-01-28 20:46:22",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please refer attachment.",
            "news_id": "428b5feb-c857-4076-8971-bd20279afdbc",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9b45bd32-998e-4451-bf41-a95b0028c16a.pdf",
            "news_date": "2024-10-26 13:43:58",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please refer attachment.",
            "news_id": "38fd8b01-af1b-4f4c-9fc4-3601ae88a9f9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6b745cfe-e39e-485e-9aad-b2d8615981f3.pdf",
            "news_date": "2024-10-23 20:16:22",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For Quarter And Half Year Ended 30Th September 2024",
            "news_body": "Please refer attachment.",
            "news_id": "1b2972f6-2879-454b-aecf-494583b94a3a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bd57c8cf-1d4a-4ed3-8967-4182ba3cbaac.pdf",
            "news_date": "2024-10-23 20:07:58",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please refer attachment.",
            "news_id": "444d1c93-abfe-47aa-a209-3caba813d963",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c3419ae7-735b-499c-8840-4308d9b6a8a3.pdf",
            "news_date": "2024-09-24 17:06:04",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "As per attachment.",
            "news_id": "6675a0e3-55da-4e8a-9dbf-8da8d83533c1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d6c1a28b-7865-404f-b326-1cd57ff20984.pdf",
            "news_date": "2024-07-29 17:20:40",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "As per attachment.",
            "news_id": "13cb4b6f-058d-4214-a9fa-4b646d79b3ce",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=773bd656-ff69-4552-9022-1a324a36e796.pdf",
            "news_date": "2024-07-26 12:52:20",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter Ended 30Th June 2024",
            "news_body": "As per attachment.",
            "news_id": "cc5ed32c-d595-4d68-b694-a2a386dbe385",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f697efe5-4196-4896-8241-84e6f3936ce6.pdf",
            "news_date": "2024-07-26 12:41:26",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Conference Call on the Audited Financial Results (Standalone and Consolidated) for the quarter and year ended 31st March 2024",
            "news_id": "2e9f66a8-3d20-4b96-80fa-ff07a060ec8b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b81638c1-2532-47c6-804e-2cfffcb28dc8.pdf",
            "news_date": "2024-05-14 19:14:11",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Conference Call on the Audited Financial Results (Standalone and Consolidated) for the quarter and year ended 31st March, 2024",
            "news_id": "e4d95cca-75d2-4e89-829c-03ffeffd33c5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=41fd3fe8-e3f8-4456-af9e-19ea97fc6dc9.pdf",
            "news_date": "2024-05-13 20:11:53",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please refer attachment.",
            "news_id": "0a2873bc-ade6-46f8-aeb0-9535f94d40ce",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e31adf91-163b-483e-8bc5-d031150ad183.pdf",
            "news_date": "2024-05-10 20:48:22",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results (Standalone & Consolidated) Of The Company For The Quarter And Year Ended 31St March, 2024",
            "news_body": "Please refer attachment.",
            "news_id": "d2b39fe1-d974-4a02-8b6f-e7eab84b5944",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3564c28a-e817-49ca-b6ce-4f3868f0fc76.pdf",
            "news_date": "2024-05-10 20:31:35",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Conference Call on the financial results (Standalone and Consolidated) for the quarter and nine months ended 31st December, 2023.",
            "news_id": "31cc2155-8c18-496c-aa77-e3b78c6a4bc4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7eae6a10-35a1-46aa-a7ef-05be49089434.pdf",
            "news_date": "2024-02-02 11:38:00",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Conference Call on the financial results (Standalone and Consolidated) for the quarter and nine months ended 31st December, 2023",
            "news_id": "a2a9d321-13cf-4d72-aed5-5a435b291374",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=988929ae-4f86-4464-9f02-531ce8dfc696.pdf",
            "news_date": "2024-01-31 20:33:39",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Press Release and Investor Presentation of Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine months ended 31st December 2023.",
            "news_id": "ce3d0aa2-9b55-4380-939c-6b4e0e7c2655",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=09998dde-6fa7-4362-a05f-36cb577314b1.pdf",
            "news_date": "2024-01-30 21:06:02",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results (Standalone & Consolidated) For The Quarter And Nine Months Ended 31St December, 2023",
            "news_body": "Unaudited Financial results (standalone & consolidated) for the quarter and nine months ended 31st December 2023",
            "news_id": "22444504-a002-4f3f-98aa-e775fc937fe3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=56bf9248-8650-4af5-bb8e-6cbe7d24000e.pdf",
            "news_date": "2024-01-30 20:52:28",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Conference Call on the financial results (Standalone and Consolidated) for the quarter and half year ended 30th September, 2023.",
            "news_id": "1247fae3-bfa9-4ec6-9c30-b69c09e9b815",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7bbea31c-3c22-4448-b5fe-2f81c4ab1e5c.pdf",
            "news_date": "2023-10-31 20:42:35",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Conference Call on the financial results (Standalone and Consolidated) for the quarter and half year ended 30th September, 2023",
            "news_id": "3fa37054-d175-48a7-bed5-a5e5dbf553a9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0df15461-4929-4b6c-9f31-b2425ec7e285.pdf",
            "news_date": "2023-10-30 16:18:21",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Press Release and Investor Presentation",
            "news_id": "4929afb0-3240-4050-94ac-5d8786897503",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eff008fb-5727-4869-a935-3b25ff3d280e.pdf",
            "news_date": "2023-10-27 22:26:27",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Meeting Of The Board Of Directors Of Piramal Pharma Limited (The 'Company') Held On 27Th October, 2023",
            "news_body": "Board Meeting Outcome - Results",
            "news_id": "7f2be1a1-d94b-4dd1-a34f-500a0a70231a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e7e6b2b4-9d6c-471b-973c-2c317d8af42d.pdf",
            "news_date": "2023-10-27 22:15:37",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of Piramal Pharma Limited (The 'Company') Held On 27Th October, 2023",
            "news_body": "Outcome of the Meeting of the Board of Directors of Piramal Pharma Limited (the 'Company') held on 27th October, 2023",
            "news_id": "125cd216-cc3e-438e-87d7-37b63d103dc2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5baea71f-a29e-4048-979c-1f37a95880d1.pdf",
            "news_date": "2023-10-27 22:13:04",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Conference Call with Investors/Analysts",
            "news_id": "e09df536-0d90-48b2-ab58-721261750e35",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c1ba1620-cbf0-4c99-8932-6d5fb601bb41.pdf",
            "news_date": "2023-08-07 20:26:02",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Conference Call with Investors/Analysts",
            "news_id": "46b32326-3229-4491-b94a-bb001e78c2a4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=49ee2aae-4c46-4f28-bc85-6d1a36850150.pdf",
            "news_date": "2023-08-07 20:19:11",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Conference Call on the financial results (Standalone and Consolidated) for the quarter ended 30th June, 2023",
            "news_id": "e418e4f2-ac36-40c6-92ac-7a0b4f79860b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=be81733e-d7c1-4ca4-97c3-d580499dca23.pdf",
            "news_date": "2023-08-04 15:05:37",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Press Release and Investor Presenation - Unaudited Financial Results(Standalone and Consolidated) of the company for quarter ended 30th June, 2023",
            "news_id": "5ae2e681-8122-4e2e-a0cf-3369a43b31fa",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0a68b299-2d4e-49b0-91be-23c34fa3d132.pdf",
            "news_date": "2023-08-03 21:11:28",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Meeting Of The Board Of Directors Of Piramal Pharma Limited Held On 3Rd August, 2023",
            "news_body": "Outcome of the Meeting of the Board of Directors of Piramal Pharma Limited held on 3rd August, 2023",
            "news_id": "7b33e674-ed12-4f1b-87cf-62eae24dfcd4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a46c570f-25d6-473b-b863-b73cd916b160.pdf",
            "news_date": "2023-08-03 21:10:09",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of Piramal Pharma Limited Held On 3Rd August, 2023",
            "news_body": "Outcome of the Meeting of the Board of Directors of Piramal Pharma Limited held on 3rd August, 2023",
            "news_id": "254744a4-cb3d-4a38-846e-352491931ac7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9b9aa5f3-5635-4142-9d0d-409fddc81a0b.pdf",
            "news_date": "2023-08-03 21:06:06",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 ('Listing Regulations') - Transcript of Conference Call with Investors/Analysts",
            "news_id": "cb143b82-87b0-4199-92d9-299746b89a12",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2afe7cf7-1cfe-4723-a414-5d13de8b76d1.pdf",
            "news_date": "2023-05-29 14:52:26",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Audio Recording Of Conference Call On The Financial Results (Standalone And Consolidated) For The Quarter And Year Ended 31St March, 2023",
            "news_body": "Audio Recording of Conference Call on the financial results (Standalone and Consolidated) for the quarter and year ended 31st March, 2023",
            "news_id": "0b93dd4e-9f01-4b7f-8641-33804bdcfc6e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3e80073f-6301-4d83-8da9-20b4e4aeba84.pdf",
            "news_date": "2023-05-25 20:27:10",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Press Release and Investor Presentation - Audited Financial Results (Standalone & Consolidated) of the Company for the quarter and year ended 31st March, 2023",
            "news_id": "e22789cd-e615-40f3-a4b3-ad917c0a72f4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=15f5da78-aed7-4b3a-a11f-f18f57b84b80.pdf",
            "news_date": "2023-05-24 22:00:07",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results (Standalone & Consolidated) For The Quarter And Financial Year Ended 31St March, 2023",
            "news_body": "Audited Financial Results (Standalone & Consolidated) for the quarter and financial year ended 31st March, 2023",
            "news_id": "43888123-2dde-46ff-868c-7d8d86efbcc2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b8e4c938-c31d-4a49-90c1-235950f68c11.pdf",
            "news_date": "2023-05-24 21:49:49",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Intimation of Conference Call with Investors/Analysts under the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015 ('Listing Regulations')",
            "news_id": "b63faf13-8bee-48bf-9172-9d7eafdec8d7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aaa99ab0-6535-4fa4-967a-e05e80f05c3e.pdf",
            "news_date": "2023-05-18 09:48:13",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Conference Call with Investors/Analysts",
            "news_id": "5a0c787c-9853-49c6-8829-40808ab26d52",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f89fd316-2534-49c7-8e0a-f88dcc77a178.pdf",
            "news_date": "2023-02-13 11:57:00",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Conference Call on the financial results (Standalone and Consolidated) for the quarter and nine months ended 31st December, 2022",
            "news_id": "0195781b-c273-4ac4-98a0-9cf5ba2b158c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3317664b-3590-4ae7-a4c6-237bead4bad5.pdf",
            "news_date": "2023-02-09 19:37:09",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Meeting Of The Board Of Directors Of Piramal Pharma Limited (The 'Company') Held On 8Th February, 2023",
            "news_body": "We wish to inform you that, the board of directors of the Company ('Board'), at its meeting held today, 8th February, 2023, has inter alia considered and approved the following:",
            "news_id": "9ee4613a-8fa9-4f38-a60d-80b06f5f4413",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7eb5ae63-8424-47b4-ab22-0a6b2e6f9226.pdf",
            "news_date": "2023-02-08 21:12:03",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations')",
            "news_id": "280456e3-e6c1-47ca-b89c-0904729bbf7b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ab423a6d-29d6-4931-a48e-39f9293fb929.pdf",
            "news_date": "2023-01-05 17:43:42",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Compliance Under Regulation 23 (9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 (Listing Regulations)",
            "news_body": "Pursuant to Regulation 23(9) of the Listing Regulations, please find enclosed herewith disclosure of related party transactions for the half year ended 30th September, 2022.",
            "news_id": "21159fc1-670b-46b1-bab0-71d06b2b6df8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5645fad5-1b1e-47f6-b310-5f6341472298.pdf",
            "news_date": "2022-11-22 21:49:03",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 ('Listing Regulations') - Transcript of Conference Call with Investors/Analysts",
            "news_id": "d936bf59-7944-4a79-bb82-01925585dd58",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b2a967d4-a3e8-4799-9372-08075b413bfc.pdf",
            "news_date": "2022-11-11 13:03:17",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Conference Call on the financial results (Standalone and Consolidated) for the quarter and half year ended 30th September, 2022",
            "news_id": "c2bbbd82-559b-4d19-b36b-66117c3d629d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a3b34206-4c49-4c71-a2cb-b00ce319689b.pdf",
            "news_date": "2022-11-09 20:25:45",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results (Standalone & Consolidated) For The Quarter And Half Year Ended 30Th September, 2022",
            "news_body": "In compliance with Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), the Board of Directors of the Company at its meeting held today, i.e. 08th November, 2022, has inter alia, approved the Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter and half year ended 30th September, 2022.",
            "news_id": "d0ede05b-e7a0-4b31-878f-b10b4b0111cb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e6a0ecca-0b6a-4b89-809c-2105acf2f971.pdf",
            "news_date": "2022-11-08 21:31:12",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Unaudited Financial Results (Standalone & Consolidated) For The Quarter And Half Year Ended 30Th September, 2022",
            "news_body": "In compliance with Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), the Board of Directors of the Company at its meeting held today, i.e. 08th November, 2022, has inter alia, approved the Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter and half year ended 30th September, 2022.",
            "news_id": "e4abc181-19c3-4792-b6ef-6ad13a3b091e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3a6325de-fddf-4780-982c-58a4893c18eb.pdf",
            "news_date": "2022-11-08 21:22:40",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        }
    ],
    "remarks": ""
}